Agrawal Papchems (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 15 Year, 20 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 342.53%
(FY 2017)
- Profit -26.22%
(FY 2017)
- Ebitda 10.75%
(FY 2017)
- Net Worth 12.78%
(FY 2017)
- Total Assets 30.13%
(FY 2017)
About Agrawal Papchems (India)
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Himanshu Shah, Ravi Shah, and Anup Shah serve as directors at the Company.
- CIN/LLPIN
U21090GJ2010PTC059179
- Company No.
059179
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Agrawal Papchems (India) Private Limited offer?
Agrawal Papchems (India) Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Inorganic Salts, Pharma Ingredients & Raw Materials, Pharmaceutical Excipients.
Who are the key members and board of directors at Agrawal Papchems (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Shah  | Director | 08-Jan-2010 | Current |
| Ravi Shah | Director | 08-Jan-2010 | Current |
| Anup Shah | Director | 08-Jan-2010 | Current |
Financial Performance of Agrawal Papchems (India).
Agrawal Papchems (India) Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 342.53% increase. The company also saw a substantial fall in profitability, with a 26.22% decrease in profit. The company's net worth Soared by an impressive increase of 12.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agrawal Papchems (India)?
In 2017, Agrawal Papchems (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Agrawal Papchems (India)?
Unlock and access historical data on people associated with Agrawal Papchems (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agrawal Papchems (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agrawal Papchems (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.